American Journal of Ophthalmology
Volume 149, Issue 1 , Pages 66-69 , January 2010

Treatment With Voriconazole in 3 Eyes With Resistant Acanthamoeba Keratitis

,Accepted 5 August 2009.

References 

  1. Thebpatiphat N, Hammersmith KM, Rocha FN, et al. Acanthamoeba keratitis: a parasite on the rise. Cornea. 2007;26:701–706
  2. Visvesvara GS, Jones DB, Robinson NM. Isolation, identification, and biological characterization of Acanthamoeba polyphaga from a human eye. Am J Trop Med Hyg. 1975;24:784–790
  3. Bacon AS, Frazer DG, Dart JK, Matheson M, Ficker LA, Wright P. A review of 72 consecutive cases of Acanthamoeba keratitis, 1984–1992. Eye. 1993;7:719–725
  4. Hargrave SL, McCulley JP, Husseini Z. Results of a trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis (Brolene Study Group). Ophthalmology. 1999;106:952–957
  5. Wilhelmus KR, Jones DB, Matoba AY, Hamill MB, Pflugfelder SC, Weikert MP. Bilateral acanthamoeba keratitis. Am J Ophthalmol. 2008;145:193–197
  6. Radford CF, Lehmann OJ, Dart JK. Acanthamoeba keratitis: multicentre survey in England 1992–6 (National Acanthamoeba Keratitis Study Group). Br J Ophthalmol. 1998;82:1387–1392
  7. Bacon AS, Dart JK, Ficker LA, Matheson MM, Wright P. Acanthamoeba keratitis (The value of early diagnosis). Ophthalmology. 1993;100:1238–1243
  8. Butler TK, Males JJ, Robinson LP, et al. Six-year review of Acanthamoeba keratitis in New South Wales, Australia: 1997–2002. Clin Experiment Ophthalmol. 2005;33:41–46
  9. Johns KJ, O'Day DM, Head WS, Neff RJ, Elliott JH. Herpes simplex masquerade syndrome: Acanthamoeba keratitis. Curr Eye Res. 1987;6:207–212
  10. Ficker L, Hunter P, Seal D, Wright P. Acanthamoeba keratitis occurring with disposable contact lens wear. Am J Ophthalmol. 1989;108:453
  11. Illingworth CD, Cook SD, Karabatsas CH, Easty DL. Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol. 1995;79:1078–1082
  12. Morlet N, Duguid G, Radford C, Matheson M, Dart J. Incidence of Acanthamoeba keratitis associated with contact lens wear. Lancet. 1997;350:414
  13. Acanthamoeba keratitis multiple states, 2005–2007. MMWR Morb Mortal Wkly Rep. 2007;56:532–534
  14. Larkin DF, Kilvington S, Dart JK. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology. 1992;99:185–191
  15. Seal DV, Hay J, Kirkness CM. Chlorhexidine or polyhexamethylene biguanide for Acanthamoeba keratitis. Lancet. 1995;345:136
  16. Duguid IG, Dart JK, Morlet N, et al. Outcome of Acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology. 1997;104:1587–1592
  17. Lim N, Goh D, Bunce C, et al. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. Am J Ophthalmol. 2008;145:130–135
  18. Murdoch D, Gray TB, Cursons R, Parr D. Acanthamoeba keratitis in New Zealand, including two cases with in vivo resistance to polyhexamethylene biguanide. Aust N Z J Ophthalmol. 1998;26:231–236
  19. Seal DV. Acanthamoeba keratitis update-incidence, molecular epidemiology and new drugs for treatment. Eye. 2003;17:893–905
  20. Schuster FL, Guglielmo BJ, Visvesvara GS. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amoebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. J Eukaryot Microbiol. 2006;53:121–126
  21. Sun MX, Chen JQ, Yao MC, Ye CT, Li J, Huang MM. [Ocular penetration and pharmacokinetics of topical voriconazole in rabbit eyes]. Zhonghua Yan Ke Za Zhi. 2008;44:349–353
  22. Vernon SE, Acar BC, Pham SM, Fertel D. Acanthamoeba infection in lung transplantation: report of a case and review of the literature. Transpl Infect Dis. 2005;7:154–157
  23. Walia R, Montoya JG, Visvesvera GS, Booton GC, Doyle RL. A case of successful treatment of cutaneous Acanthamoeba infection in a lung transplant recipient. Transpl Infect Dis. 2007;9:51–54
  24. Kosrirukvongs P, Wanachiwanawin D, Visvesvara GS. Treatment of Acanthamoeba keratitis with chlorhexidine. Ophthalmology. 1999;106:798–802
  25. Gooi P, Lee-Wing M, Brownstein S, El-Defrawy S, Jackson WB, Mintsioulis G. Acanthamoeba keratitis: persistent organisms without inflammation after 1 year of topical chlorhexidine. Cornea. 2008;27:246–248
  26. Clarke DW, Alizadeh H, Niederkorn JY. Failure of Acanthamoeba castellanii to produce intraocular infections. Invest Ophthalmol Vis Sci. 2005;46:2472–2478

PII: S0002-9394(09)00552-2

doi: 10.1016/j.ajo.2009.08.004

American Journal of Ophthalmology
Volume 149, Issue 1 , Pages 66-69 , January 2010